UMIN-ICDS History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000063248
Receipt number	R000072313
Scientific Title	A multicenter prospective observational study of the effectiveness and safety of amivantamab-based regimens (MARIPOSA/MARIPOSA-2) after first-line osimertinib-based therapy in patients with EGFR mutation-positive non-small cell lung cancer (NEJ073)
Date of disclosure of the study information	2026/10/13
Last modified on	2026/10/13 09:12:29

---